loimmune responses that culminate in tubular injury, interstitial fibrosis, and subsequent CAF, a paramount prediction model is not possible without considering components of genetic diversity that regulates alloimmune responses. As the alloimmune response represents a complex process, wherein cytokines act as chief mediators or regulators of inflammation, studies on genetic predisposition for heritable allelic differences in the genes encoding various proinflammatory and regulatory cytokines are an obvious attraction. Genetic control of cytokine production is evidenced by the identification of polymorphisms in cytokine gene regulatory regions that produce low, moderate, or high cytokine expression profiles (6 -9) . Theoretically, a genotype associated with overexpression of proinflammatory cytokine would be detrimental, whereas that of a regulatory cytokine is advantageous for the better graft survival.
Many studies analyzed the associations between polymorphisms in cytokine promoter genes and transplantation outcomes but with conflicting results (10 -13) , primarily due to failure in clearly defining the endpoints, such as the time point, and the method of diagnosis. This is further complicated by the fact that CAF is a multifactorial disease and represents the cumulative response to injury, regardless of the causative factor (14 -16) . To address this situation, the revised Banff Schema for grading biopsies has replaced the popular but misleading term "chronic allograft nephropathy" with an index called as morphologic features of interstitial fibrosis and tubular atrophy (IF/TA) not otherwise specified. This may aid in differentiating immune from nonimmune processes leading to pathogenesis of CAF (17) . We have previously shown that histologic scores at 6-to 12-month biopsies are strongly associated with CAF and graft dysfunction (3) (4) .
In this investigation, we used various histologic scores and inflammatory cell infiltration (T cell, B cells, and macrophages) as the clinical endpoints to determine the predictive potential of cytokine gene polymorphisms. We examined the association of 15 cytokine gene variants with 11 individual histologic scores, the combined score of IF/TA, and the total number of infiltrated inflammatory cells observed in 6-to 12-month TSBs taken from 218 kidney transplant recipients.
MATERIALS AND METHODS

Subjects
From a total of 536 renal transplants performed during 1997 to 2006 at the Southern Alberta Transplant Program, 218 adult recipients (41% of total transplant recipients) were included in this retrospective study. The inclusion criteria were the availability of both DNA specimens and the respective 6-to 12-month TSB results. All subjects gave their informed consent before their transplantations for TSBs to be used for evaluating the quality of our program and in developing future diagnostic modalities. The Ethics Committee of the University of Calgary approved the study.
Histologic Quantitation of TSBs
Transplant surveillance biopsies (TSBs) are kidney biopsies performed after renal transplants in consenting patients to allow early diagnosis of subclinical acute and chronic histologic changes and subsequent intervention. Since 1998, we have been routinely performing prospective TSBs at our center. TSBs consisted of two core samples obtained with 18-gauge needles using ultrasound guidance in the Radiology Department in our institution. Paraffin and plastic sections of TSBs were prepared and stained with heamatoxylin-eosin, Masson's trichrome, periodic acid-Schiff, and periodic acid-Schiff-methanamine-silver stains. A transplant pathologist who was blinded to therapy and initial diagnosis of the case independently examined each biopsy under light microscopy. TSBs were scored for various histologic parameters only if at least one artery and seven glomeruli were present in the biopsy specimen (5) . The following histologic parameters were graded using Banff '97 thresholds (18) : tubular atrophy (ct), glomerular mesangial matrix increase (mm), interstitial fibrosis (ci), fibrous intimal thickening (cv), allograft glomerulopathy (cg), arteriolar hyaline thickening (ah), glomerular sclerosis (gs), mononuclear cell interstitial inflammation (i), tubulitis (t), allograft glomerulitis (g), and intimal arteritis (v). The combined score of IF/TA was graded by the revised Banff Schema (17) . Each parameter was scored as 0 (normal), 1 (mild), 2 (moderate), or 3 (severe). For data collection and analysis, the Southern Alberta Transplant Program real-time transplant database was used (5) .
Immunohistochemical Staining
In the 6-to 12-month TSBs of 141 recipients, T-cell, B-cell, and macrophage infiltrate immunostaining using monoclonal antibodies directed to CD20, CD3, and CD68 antigens, respectively, quantified inflammation. Paraffin-embedded sections were deparaffinized with xylene two times for 5 min and gradually hydrated with 100% ethyl alcohol, 95% ethyl alcohol, and 70% ethyl alcohol two times for 1 min. Antigen retrieval was carried out using Cell Conditioning Solution (Ventana, catalogue no. 950124, Tucson, AZ) for 30 min. The slides were incubated with anti-CD3 rabbit monoclonal antibody (Neomarkers clone SP7, catalogue no. RM-9107-S, 1/200, Fremont, CA), anti-CD20 mouse monoclonal antibody (DAKO clone L26, catalogue no. NP004, 1/200, Mississauga, ON, Canada), or anti-CD68 mouse monoclonal antibody (DAKO clone KP1, catalogue no. N1577, 1/5000) for 32 min at 37°C using an automated BenchMark XT IHC staining system with XT ultraView DAB detection kit (Ventana, catalogue no. 760500). Analysis of cellular infiltrates was performed blinded, by assessing the number of positive cells in 10 consecutive high-power fields (400ϫ magnification) of cortex for each section.
Cytokine Polymorphism Genotyping
Cytokine genotyping was performed using a multiplex cytokine genotyping assay using Lifecode Cytokine genotyping kit (Genprobe, Stamford, CT). The assay is based on Luminex xMAP technology and sequence-specific oligogonucleotide methodology. The genotyping was performed for 15 singlenucleotide polymorphisms (SNPs) located in promoter or exonic region of genes of 10 different cytokines or their receptors. The genotyped SNPs include tumor necrosis factor-␣ (G/A at Ϫ308 and G/A at Ϫ238), interferon-␥ (A/T at ϩ874), interleukin (IL)-10 (G/A at Ϫ1082, C/T at Ϫ819, and C/A at Ϫ592), IL-6 (C/G at Ϫ174), IL-1␣ (T/C at Ϫ889), IL-1␤ (C/T at Ϫ511 T/C at ϩ3954), IL-1 receptor (IL-1R) (C/T at pstl 1970), IL-1 receptor agonist (C/T at mspal 11100), IL-12B (A/C at Ϫ1188), and transforming growth factor-␤ (C/T at ϩ869 and C/G at ϩ915).
Statistical Analyses
Statistical analyses were performed using SPSS software, version 15.01 (SPSS Inc., Chicago, IL). The Goodness-of-fit chi-square test was used to examine deviation from Hardy-Weinberg Equilibrium. Each of the 12 histologic scores (scored from 0 -3) was considered high (if Ն1) or low (if Ͻ1). Univariate analysis was performed using Fischer's exact test to investigate the impact of cytokine polymorphism genotypes on IF/TA grading and various histologic scores. Corrected P values (Pc) were calculated as product of the P value and total number of SNPs analyzed to rule out getting a significant different by chance. Odds ratios (ORs) at 95% confidence intervals (CIs) were determined to describe the strength of association between the genotypes and the histologic scores using a binary logistic regression model. Linkage disequilibrium (as measured by r 2 ) was computed for each pair of SNPs within each gene (19) . Univariate analysis was also performed for various demographic and clinical parameters using IF/TA or inflammation score as the dependent variables. Two multiple logistic regression models were then used for the multivariate analysis wherein scores for IF/TA and inflammation were used as dependent variables, respectively. All variables (genotypes and clinical and demographic parameters) that were found significantly associ-ated with IF/TA or inflammation (PϽ0.05) in the univariate analysis were included as independent variables in their respective models. The evaluation of the corresponding effect of these variables was evaluated using stepwise elimination procedure. The distribution of continuous baseline characteristics (number of T cells, B cells, or macrophages scored in 6-to 12-month TSBs) was represented as median with 25th and 75th percentiles. Significance of difference of test results for the continuous data between two groups (low or high cytokine-expressing genotypes) was tested by Mann-Whitney-Wilcoxon rank sum test. A P value of less than 0.05 was considered significant.
RESULTS
Demographic and Clinical Characteristics
The patients in this study received their transplant between 1997 and 2006, with a mean time between the transplant and collection of the TSB being 224Ϯ66 days. Of the 218 patients, 55% were male and 72% were whites. The mean age at the time of the TSB was 47.5Ϯ13 years (range 12-79 years). Diabetes or hypertension was the primary disease in 28% of patients. Seventy percent of patients received a kidney from a deceased donor. The mean donor age was 36Ϯ17 years, and the mean cold ischemia time was 10Ϯ7 hr. The number of human leukocyte antigen (HLA) class I (HLA-A or HLA-B) and class II mismatches (HLA-DR or HLA-DQ) (Ͼ0) was 59% and 63%, respectively.
Histologic Parameters of TSBs
Two hundred eighteen 6-to 12-month TSB results were included in this study. A total of 11 histologic parameters were scored and are shown in Table 1 . The IF/TA grade was calculated based on individual scoring of IF/TA. A histologic grade of more than or equal to 1 was observed in the majority of the 218 patients for IF/TA (64% of patients), tubular atrophy (ct) (64%), mesangial matrix (mm) (58%), and interstitial fibrosis (ci) (51%). The other histologic parameters had 19% to 43% of patients showing a score of more than or equal to 1, with the exception of allograft glomerulopathy (cg) and intimal arteritis (v), which had more than 99% of patients with a normal profile (scoreϭ0; Table 1 ). These two parameters were excluded from further analyses. In the univariate analysis, donor age, donor type, donor hypertension, and mismatch at HLA class I (HLA-A or HLA-B) and II (HLA-DR or HLA-DQ) loci between recipient and donor were found significantly associated with an IF/TA grade of more than or equal to 1 (Table 2) . Conversely, number of HLA mismatches between recipient and donor, episode of acute rejection, and type of immunosuppressant showed significant association with an inflammation grade of more than or equal to 1 ( Table 2) .
Association of Cytokine Polymorphism Genotypes With the IF/TA Grades
A total of 15 SNPs present in 10 cytokine genes or their receptors were assessed for association with the IF/TA grade of 6-to 12-month TSBs (Table 3 ). In the univariate analysis, low-expressing genotype for two SNPs located in the promoter region of the gene encoding the regulatory cytokine IL-10, namely IL-10 Ϫ819 TT (Pϭ0.003; ORϭ4.3; 95% CIϭ1.4 -10.1) and IL-10 Ϫ592 AA (Pϭ0.016; ORϭ2.6; 95% CIϭ1.54 -5.8), were found to be significantly associated with an IF/TA grade of more than or equal to 1. No statistically significant associations between any other polymorphisms tested and IF/TA grade were observed. However, only the IL10 Ϫ819 TT genotype showed a significant association when more stringent corrected P values (Pc value) were calculated (Pcϭ0.045). The two IL-10 polymorphisms, IL-10 Ϫ819 C/T and Ϫ592 C/A, were found in high linkage disequilibrium (r 2 ϭ0.77). A stronger association with IF/TA grade was observed (Pϭ0.001; ORϭ5.7; 95% CIϭ1.8 -18.5) when the two IL-10 promoter SNPs (Ϫ819 C/T and Ϫ592 C/A) were assessed together (CC/CC vs. AT/AT). Multivariate analysis with stepwise elimination procedure further corroborated significant association of IL-10 Ϫ819TT genotypes with IF/TA grade of more than or equal to 1 (Pϭ0.035; ORϭ3.27; 95% CIϭ1.1-9.8) when analyzed with selected demographic and clinical parameters as independent variables (for selection criteria, see Materials and Methods section). IL-10 Ϫ592AA genotype did not show significant association with IF/TA in the multivariate analysis. Other parameters found associated with IF/TA grade more than or equal to 1 were donor's age and HLA class I (HLA-a or HLA-B) mismatch between donor and recipient (Table 4) . 
Association of IL-10 ؊819 C/T With Histologic Indices
The high-and low-expressing genotypes of IL-10 Ϫ819 C/T were then assessed for their association with nine histologic parameters. In the univariate analysis, low-expressing IL-10 Ϫ819 TT genotype showed a significant association with interstitial fibrosis (Pϭ0.0005, ORϭ4.6, 95% CIϭ1.9 -11.3), tubular atrophy (Pϭ0.003, ORϭ4.3, 95% CIϭ1.5-12.2), and interstitial inflammation (Pϭ0.02, ORϭ2.7, 95% CIϭ1.2-6.2) scores (Table 5) . Multivariate analysis for association of IL-10 Ϫ819 TT genotypes with interstitial inflammation with selected demographic and clinical parameters also showed significant association (Pϭ0.05; ORϭ2.8; 95% CIϭ1.0 -7.4; Table 5 ).
Association of IL-10 ؊819 C/T and ؊592 C/A Genotypes With Inflammatory Cells Infiltrating the Renal Allograft
Because infiltration of inflammatory cells (T cells, B cells, and macrophages) in the renal allograft interstitium is a biologic hallmark of alloimmune responses, we assessed the association of two IL-10 promoter SNPs with the total number of infiltrated inflammatory cells (CD3 ϩ T cells, CD20 ϩ B cells, and CD68 ϩ macrophages) scored in the 6-to 12-month TSBs (Fig. 1) . A 3-fold increase (Pϭ0.01) in total number of CD3 ϩ T cells and a 2.5-fold increase (Pϭ0.006) in the total number of CD68 ϩ macrophages were found in renal transplant recipients carrying the low-expressing (TT) when compared with the high-expressing (CC) IL-10 Ϫ819 T/C genotype. The low-expressing (AA) genotype of IL-10 Ϫ592 A/C was also significantly associated with high numbers of CD68 ϩ macrophages (Pϭ0.003). No significant difference in the infiltration of inflammatory cells was observed between patients carrying high-and intermediate-expressing IL-10 genotypes (between Ϫ819 CC and TC and between Ϫ592 CC and AC).
DISCUSSION
The personalized medicine paradigm, in contrast to the "one-treatment-fits-all" approach, recommends the tailoring of diagnostic and therapeutic treatments for every individual patient, presumably dictated by the information on genetic predisposition. This may lead to timely prediction of CAF and allow better protocols for immunosuppressive medications. Given the central role of cytokines in the regulation of alloimmune responses, polymorphisms in cytokine gene regulatory regions are the second most studied immunogenetic system after HLA for their association with renal transplant outcomes (mainly with episodes of acute rejection), but with varying results (10 -13) . However, studies on the influence of cytokine polymorphism on CAF are limited and have been affected by inadequate power to detect a difference or with inadequately defined endpoints. This investigation is the first report on the association of 15 cytokine polymorphisms with individual histologic indices that are characteristic of CAF and with inflammatory cells infiltration scored in 6-to 12-month TSBs. The study presents two major findings: (1) kidney allograft recipients with low-expressing IL-10 genotypes have higher likelihood of having high IF/TA grades and high individual scores for IF/TA when compared with the high-expressing genotypes and (2) lowexpressing IL-10 genotypes were significantly associated with interstitial inflammation and with high numbers of T cells and macrophages, but not B cells, in the renal allograft interstitium. The results suggests that genetic predisposition to a deficient regulatory milieu may represent a crucial determinant of chronic renal allograft damage leading to CAF. CAF is a multifactorial progressive disorder, wherein several factors apart from the alloimmune responses (e.g., hypertension, chronic calcineurin inhibitor toxicity, infections) may play a detrimental role. This is crucial because renal biopsies with high IF/TA scores may have other recognizable pathologic changes that may represent other confounding factors (17) . Other factors that are more likely to influence the association of IL-10 gene polymorphism include earlier episodes of acute rejection (24% of patients had acute rejection), donor hypertension (11% donors were hypertensive), type of immunosuppressant used (42% patients were treated with cyclosporine A), donor's age (22% donors were 50 years or older), and HLA mismatch (84% patientdonor pairs have Ն2 mismatched HLA antigens), as each of these were found significantly associated with IF/TA or inflammation in the univariate analysis (Table 2 ). To address this problem, we used two approaches; first, we selected individual histologic indices and infiltration of inflammatory cells in the renal interstitium as the endpoints because an alloimmune response leading to a high IF/TA grade could be represented by high scores for interstitial inflammation and high influx of inflammatory cells into the renal interstitium. Second, we used a multivariate analysis to evaluate the corresponding effect of significant demographic and clinical parameters using two multiple logistic regression models, wherein scores for IF/TA and inflammation were used as dependent variables, respectively. The results clearly demonstrated that low-expressing IL-10 genotypes (Ϫ592 AA and Ϫ819 TT) are associated with high grade for IF/TA, interstitial inflammation, and infiltration of T cells and macrophages in the renal interstitium. The findings were true even in multivariate analysis when the effect of confounding variables was evaluated using stepwise elimination procedure.
IL-10 is the major regulatory cytokine mainly produced by monocytes, T cells, and regulatory T cells (20) and is considered to be essential for peripheral tolerance to allergens, autoantigens, and transplant antigens, mainly due to its varied regulatory functions. These functions include containment of inflammatory cytokine secretion, inhibition of proliferation or activation of T cells and natural killer cells and profound suppression of a broad spectrum of macrophage or monocyte functions including monokine production (20) . Within the IL-10 gene, three SNPs in the promoter region at positions Ϫ1082 (A to G substitution), Ϫ819 (C to (Table 3) were included in the multivariate analysis. Results shown here are for the IL-10 Ϫ819 TT genotype and other variables with significant results in the multivariate analysis using step-wise elimination procedure.
IL, interleukin; CI, confidence interval.
T), and Ϫ592 (C to A) have been correlated with different levels of IL-10 production in stimulated lymphocytes. The Ϫ1082 GG, Ϫ819 CC, and Ϫ592 CC genotypes are "high IL-10 producers" (6, 8) . Theoretically, a genotype associated with overexpression of IL-10 cytokine would be advantageous, whereas that leading to underexpression is detrimental for the graft survival. The association between low-expressing IL-10 genotypes and haplotypes with high IF/TA grade, interstitial inflammation scores, and high infiltration of inflammatory cells is consistent with this hypothesis and can be explained in light of the inflammatory events involved in the pathogenesis of CAF. The influx of inflammatory cells (T cells, macrophages, and B cells) in the renal interstitium leads to tubulointerstitial injury. The persistent inflammatory cytokine activity during chronic renal inflammation along with the tubular injury culminates in a process called epithelialmesenchymal transition that leads to proliferation in fibrogenic tissues causing interstitial fibrosis (21) . Because IL-10 production can regulate several of these underlying events, a genetic predisposition for low IL-10 expression may augment the pathogenesis of CAF. In support of this, Mu et al. (22) has convincingly shown diminution in influx of inflammatory cells and expression of inflammatory chemokines associated with significant reduction in interstitial fibrosis when recombinant IL-10 was administered to rats in which chronic renal disease was induced with a partial nephrectomy. Although we did not find any association of IL-10 genotypes with the total number of B cells scored in the renal interstitium, this was not unexpected, as data from animal studies based on administration of IL-10 protein, delivery of the IL-10 gene, inhibition by anti-IL-10 neutralizing monoclonal antibodies, or use of IL-10 transgenic or IL-10 knockout animals suggest that the in vivo role of IL-10 in B-cell function is limited (23, 24) . Although it may be possible that IL-10 does not have a direct effect on total B-cell numbers, it may affect the differentiation of alloantigen-specific B cells into IgG-secreting plasma cells. Several plausible mechanisms for the functional effect of the IL-10 Ϫ592 A/C or Ϫ819 T/C polymorphisms on IL-10 expression have been reported. The Ϫ592 A/C SNP is located between two recognized consensus sequences that form the binding sites for SP1, an important transcription activator (25) , and the Ϫ819 T/C SNP is located in the positive regulatory region of the IL-10 gene (26) . Consistent with earlier reports, we found that IL-10 Ϫ819 T/C polymorphism is in linkage disequilibrium with the Ϫ592 C/A polymorphism, but not Ϫ1082 A/G. Although Ϫ1082 A/G polymorphism is the most frequently studied IL-10 polymorphism in renal transplantation (again with varying outcomes) (25, 27, 28) , we did not find any significant association between this polymorphism and the measured histologic or immunologic indicators. The results are consistent with previous studies showing association of IL-10 promoter SNPs with biopsyproven episodes of rejection (25, 29, 30) .
There are important limitations in the interpretation of our findings of association of IL-10 low-expressing genotypes with high IF/TA grade and interstitial inflammation scores and with high influx of inflammatory cells into renal interstitium. First, the association of IL-10 low-expressing genotypes with high IF/TA grade might not be sufficient to stratify patients as low-or high-risk patients. Based on the results presented in this study, IL-10 Ϫ819 genotyping has a high specificity (ϳ90%) but low sensitivity (ϳ35%) to predict a high IF/TA grade. In such a scenario, the IL-10 genotyping can rule out "high risk" patients, but it cannot identify a "low risk" patient. This might be because factors other than genetic predisposition might also influence the functional expression of proteins and polypeptides, and therefore, recipients predisposed to produce low amounts of IL-10 may actually produce more under certain circumstances. We cannot rule out this possibility because we did not directly measure cytokine expression levels in pre-TSB or TSB plasma samples. A better and broader predictive model involving both genetic and histologic markers could provide a superior diagnostic option. Second limitation is the possible bias of population stratification, which may not have been an extensive limiting factor here, because more than 70% of the renal transplant recipients included in the study were whites.
In conclusion, kidney allograft recipients genetically predisposed to produce low amounts of IL-10 are strongly associated with high IF/TA grade and interstitial inflammation scores and with high influx of inflammatory cell in the renal allograft interstitium, but not with other tested histologic parameters. This suggests that a deficient regulatory milieu and not an aggressive inflammatory assault may represent a crucial predictor of chronic renal allograft damage. The results generated from this investigation will provide an important piece for a more comprehensive mathematical model predicting long-term renal transplant outcomes.
